Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $60 | $110 | $102 | $97 |
| Short-Term Investments | $41 | $39 | $128 | $1 |
| Receivables | $165 | $193 | $195 | $268 |
| Inventory | $51 | $75 | $83 | $109 |
| Other Curr. Assets | $37 | $43 | $56 | $36 |
| Total Curr. Assets | $353 | $461 | $554 | $512 |
| Property Plant & Equip (Net) | $59 | $53 | $51 | $226 |
| Goodwill | $0 | $0 | $0 | $22 |
| Intangibles | $542 | $569 | $569 | $405 |
| Long-Term Investments | $0 | $15 | $0 | $0 |
| Tax Assets | $0 | $0 | $23 | $118 |
| Other NC Assets | $61 | $45 | $2 | $4 |
| Total NC Assets | $662 | $683 | $695 | $776 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,015 | $1,143 | $1,248 | $1,288 |
| Liabilities | – | – | – | – |
| Payables | $30 | $21 | $32 | $64 |
| Short-Term Debt | $39 | $35 | $14 | $408 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $7 | $8 | $121 |
| Other Curr. Liab. | $192 | $251 | $257 | $16 |
| Total Curr. Liab. | $261 | $314 | $311 | $610 |
| LT Debt | $3 | $35 | $33 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $7 | $9 | $6 |
| Other NC Liab. | $381 | $333 | $261 | $109 |
| Total NC Liab. | $383 | $375 | $303 | $120 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $7 | $8 | $8 |
| Total Liabilities | $644 | $689 | $614 | $731 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,226 | $1,224 | $1,234 | $1,239 |
| Retained Earnings | -$1,041 | -$944 | -$770 | -$822 |
| AOCI | $185 | $174 | $170 | $149 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $370 | $454 | $634 | $565 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | -$8 | -$8 |
| Total Liab. & Tot. Equity | $1,015 | $1,143 | $1,248 | $1,288 |
| Net Debt | -$19 | -$40 | -$54 | $317 |